
    
      This is a prospective, open-label, single center clinical study to be enrolled at George
      Washington University Medical Center. This study will consist of 10 patients and each patient
      will be assessed at pre-treatment, pre-discharge, and at 1 and 3 months post treatment.
      Outcomes to be evaluated include: pain severity, disability, and the occurrence of adverse
      events.
    
  